Reuters logo
BRIEF-Neogenomics says neolab liquid biopsy prostate test is more accurate than conventional biopsies
May 15, 2017 / 1:20 PM / 5 months ago

BRIEF-Neogenomics says neolab liquid biopsy prostate test is more accurate than conventional biopsies

May 15 (Reuters) - Neogenomics Inc:

* Neogenomics reports that its neolab(r) liquid biopsy prostate test is more accurate than conventional biopsies in predicting high grade prostate cancer

* Neogenomics-New clinical trial showed sensitivity of neolab liquid biopsy prostatetest was 97 pct in predicting presence of high grade prostate cancer Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below